V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007392 | 290005706 | null | null | Palliative (P) | 2018-09-14 | 2018-09-21 | Capecitabine | N | Y | 290025330 | CETUXIMAB + IRINOTECAN + MDG |
| 290007393 | 290005707 | 1.8 | 67.3 | Palliative (P) | 2018-12-05 | 2018-12-14 | Sunitinib | N | Y | 290025374 | PACLITAXEL |
| 290007394 | 290005708 | 1.65 | 82.2 | Palliative (P) | 2017-02-04 | 2017-02-08 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | N | N | 290025399 | TEMOZOLOMIDE |
| 290007395 | 290005709 | 1.83 | 89.6 | Adjuvant (A) | 2016-03-12 | 2016-03-26 | FEC 100 | 02 | null | 290025403 | CAPECITABINE + OXALIPLATIN |
| 290007396 | 290007429 | 1.6 | 62.4 | Palliative (P) | 2016-06-26 | 2016-06-29 | CHOP R - 21 days | N | N | 290025435 | IRINOTECAN |
| 290007397 | 290005710 | 0 | 60.8 | Palliative (P) | 2016-01-03 | 2016-02-11 | Cisplatin + Radiotherapy | 2 | Y | 290025445 | DOXORUBICIN + OLARATUMAB |
| 290007398 | 290005711 | 1.68 | 56 | Neo-adjuvant (N) | 2017-06-12 | 2017-06-13 | Capecitabine + Oxaliplatin 21day | N | N | 290025461 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007399 | 290005712 | null | 70 | Palliative (P) | 2017-09-19 | 2017-09-27 | CAPECITABINE + MITOMYCIN + RT | N | N | 290025534 | OCTREOTIDE |
| 290007400 | 290005714 | 1.5 | null | Not known (9) | 2015-04-01 | 2015-04-07 | CARBOPLATIN | N | N | 290025542 | RITUXIMAB |
| 290007401 | 290008328 | 0 | null | Palliative (P) | 2017-03-23 | 2017-04-06 | Cetuximab 7 day (>Cycle 2) | N | N | 290025560 | DOCETAXEL |
| 290007402 | 290008080 | null | 66.6 | null | 2016-03-27 | 2016-04-17 | Cisplatin + Radiotherapy | N | N | 290025572 | CAPECITABINE |
| 290007403 | 290005715 | 1.79 | 48.3 | Curative (C) | 2017-05-16 | 2018-01-04 | INTERAACT trial | 2 | N | 290025865 | CARBOPLATIN + RT |
| 290007404 | 290005716 | null | null | Curative (C) | 2013-09-14 | 2013-09-14 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 290025908 | CISPLATIN + RT |
| 290007405 | 290005716 | 1.69 | 48 | Disease modification (D) | 2017-12-20 | 2017-12-20 | Sunitinib | N | N | 290025908 | FLUOROURACIL + MITOMYCIN |
| 290007406 | 290005716 | 1.8 | 65.2 | Palliative (P) | null | 2016-05-08 | Cisplatin 7 day | N | N | 290025908 | CAV |
| 290007407 | 290007432 | 1.69 | null | Palliative (P) | 2018-03-08 | 2019-02-02 | PEMBROLIZUMAB | N | Y | 290026213 | CAPECITABINE + CISPLATIN |
| 290007408 | 290005718 | null | 105.5 | Palliative (P) | null | 2018-05-13 | CETUXIMAB + RT | N | Y | 290026225 | CAPECITABINE + CISPLATIN |
| 290007409 | 290005719 | 1.62 | 107 | Neo-adjuvant (N) | 2017-01-23 | 2017-01-24 | LANREOTIDE | N | N | 290026279 | NOT MATCHED |
| 290007410 | 290005719 | null | null | Adjuvant (A) | 2014-08-30 | 2014-09-06 | NIVOLUMAB | N | Y | 290026279 | CARBO + FLUOROURACIL |
| 290007411 | 290005720 | 1.68 | 89 | Palliative (P) | 2019-05-08 | 2019-05-25 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 290026431 | VINORELBINE |
| 290007412 | 290005722 | 1.57 | 67.7 | Disease modification (D) | null | 2017-05-03 | CAPECITABINE + MITOMYCIN + RT | N | N | 290026431 | HYDROXYCARBAMIDE |
| 290007413 | 290005722 | 1.87 | null | Palliative (P) | 2019-02-24 | 2019-03-23 | FLUOROURACIL + MITOMYCIN | N | Y | 290026431 | LANREOTIDE |
| 290007414 | 290005723 | 1.63 | null | Curative (C) | 2017-07-26 | 2017-08-04 | Carboplatin AUC 6 - 10 | 02 | Y | 290026759 | CISPLATIN + FLUOROURACIL + RT |
| 290007415 | 290005723 | 1.66 | 52 | Disease modification (D) | 2016-10-20 | 2016-11-15 | CompARE Trial | N | N | 290026759 | RITUXIMAB |
| 290007416 | 290005725 | 1.68 | 57 | Adjuvant (A) | 2018-11-22 | 2018-12-04 | Sunitinib | 2 | N | 290026832 | CISPLATIN + ETOPOSIDE |
| 290007417 | 290005727 | 1.73 | 104.2 | null | 2018-07-27 | 2018-07-27 | Trial Unspecified | null | N | 290026832 | LANREOTIDE |
| 290007418 | 290005728 | 1.75 | 73.3 | Neo-adjuvant (N) | 2017-10-16 | 2018-02-23 | Cisplatin 7 day | 02 | N | 290026954 | CISPLATIN + FLUOROURACIL + RT |
| 290007419 | 290005728 | 1.55 | 60.6 | Palliative (P) | 2017-05-28 | 2017-05-28 | Capecitabine (14 day) + Irinotecan | N | N | 290026954 | IRINOTECAN |
| 290007420 | 290005729 | 1.81 | 85.85 | Palliative (P) | 2014-09-03 | 2016-01-14 | Oxaliplatin + Raltitrexed | 02 | N | 290026996 | IPILIMUMAB |
| 290007421 | 290005730 | 1.6 | 50 | Adjuvant (A) | 2013-09-28 | 2013-10-04 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 290027078 | CAPECITABINE |
| 290007422 | 290005731 | 1.71 | null | Adjuvant (A) | 2018-07-13 | 2018-07-13 | Panitumumab | N | N | 290027215 | CAPECITABINE + OXALIPLATIN |
| 290007423 | 290005732 | 1.81 | 84.4 | Palliative (P) | 2015-06-02 | 2015-06-28 | Carboplatin + Paclitaxel (3 weekly) | N | N | 290027439 | PACLITAXEL |
| 290007424 | 290005733 | null | 75.2 | Palliative (P) | 2017-08-23 | 2017-08-23 | Cetuximab + Radiotherapy Maint | 02 | N | 290027474 | INTERAACT TRIAL |
| 290007425 | 290007442 | 1.62 | 89.6 | Palliative (P) | 2017-06-12 | 2017-06-25 | OCTREOTIDE | 02 | N | 290027501 | EOX |
| 290007426 | 290007442 | 1.66 | 75.6 | null | 2015-01-03 | 2015-01-30 | Trial Unspecified | null | N | 290027501 | CETUXIMAB + RT |
| 290007427 | 290005735 | 1.65 | 76.1 | Palliative (P) | 2017-04-23 | 2017-04-23 | Sunitinib | 2 | N | 290027678 | CARBOPLATIN + ETOPOSIDE |
| 290007428 | 290007443 | null | 61 | Palliative (P) | null | 2014-04-29 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 290027685 | CAPECITABINE + OXALIPLATIN |
| 290007429 | 290005736 | 1.68 | 76.1 | Palliative (P) | 2018-03-16 | 2018-03-25 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | N | 290000041 | CAPECITABINE + CISPLATIN |
| 290007430 | 290005737 | 1.62 | 54.4 | Palliative (P) | 2016-12-03 | 2017-01-06 | CAV | N | N | 290005184 | CAPECITABINE + CISPLATIN |
| 290007431 | 290005739 | 1.84 | 86.6 | Curative (C) | null | 2017-11-02 | null | N | N | 290005184 | CISPLATIN |
| 290007432 | 290005741 | null | 76 | Palliative (P) | 2015-05-09 | 2015-05-14 | null | N | N | 290009639 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290007433 | 290005742 | 1.62 | 71 | Adjuvant (A) | 2017-07-13 | 2017-07-20 | Trial Unspecified | N | N | 290010297 | CETUXIMAB + RT |
| 290007434 | 290005743 | 1.76 | 108 | Curative (C) | null | 2016-04-01 | Capecitabine 42days + RT | N | Y | 290010587 | CISPLATIN + RT |
| 290007435 | 290005744 | null | 89 | Palliative (P) | 2019-03-06 | 2019-03-28 | null | 2 | N | 290011095 | PCV |
| 290007436 | 290005747 | 1.57 | 51.5 | Palliative (P) | 2014-11-16 | 2015-01-04 | Cetuximab + Radiotherapy Maint | N | N | 290012031 | CAPECITABINE + CARBOPLATIN |
| 290007437 | 290005748 | 1.68 | 92.5 | Curative (C) | 2017-04-02 | 2017-04-07 | Cetuximab + FOLFIRI cycle 2 onwards | 1 | Y | 290015961 | CAPECITABINE + MITOMYCIN + RT |
| 290007438 | 290005749 | 1.9 | 84.3 | Curative (C) | 2018-12-02 | 2018-12-29 | Cisplatin + Radiotherapy | N | N | 290016398 | CAPECITABINE + RT |
| 290007439 | 290005750 | 1.71 | 0 | Palliative (P) | null | 2018-02-27 | CETUXIMAB + RT | N | N | 290016522 | CYCLOPHOSPHAMIDE |
| 290007440 | 290005751 | 0 | null | Curative (C) | null | 2014-08-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290016717 | CISPLATIN + RT |
| 290007441 | 290005752 | 1.67 | 86.7 | Palliative (P) | 2017-08-26 | 2017-09-07 | Cetuximab + Radiotherapy Maint | 02 | N | 290017354 | IPILIMUMAB |